Time & Date: 1 September, 11:45 – 12:45 CEST
Chairpersons: C. Klaver NETHERLANDS & C. Hoyng NETHERLANDS
Speakers & Presentations:
C. Klaver NETHERLANDS
11:45 Introduction
D. Fischer GERMANY
11:47 AAV-based subretinal gene therapy for IRDs
R. Collin THE NETHERLANDS
12:02 Antisense Oligonucleotide therapy in retinal disease
B. Leroy USA
12:17 Why current genetic therapies in IRDs often fail
All Faculty
12:32 Discussion
